1. Vasilyeva I.A. et al. Incidence, mortality and prevalence as indicators of tuberculosis burden in WHO regions, countries of the world, and the Russian Federation. Part 1. Tuberculosis incidence and prevalence. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 6, pp. 9-21. (In Russ.)
2. Nechaeva O.B. Аnaliticheskiy obzor situatsii po tuberkulezu v Rossii v 2016 godu. [Analytic review of tuberculosis situation in Russia in 2016]. Moscow, 2016, 69 p.
3. Nechaeva O.B. Analitichesky obzor osnovnykh statisticheskhy pokazateley po tuberkulezu v Rossii. [Analytic review of main tuberculosis statistic rates used in Russia]. Moscow, 2017, 4 p.
4. Ahuja S.D., Ashkin D., Avendano M. et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9153 patients. PLos Med., 2012, vol. 9, Available at: https://www.ncbi.nlm.nih.gov/pubmed/22952439. Accessed: 19.03.2018.
5. Barry P.J., O’Connor T.M. Novel agents in the management of Mycobacterium tuberculosis disease. Curr. Med. Chemistry, 2007, vol. 14, no. 18, pp. 2000-2008.